By Novo Nordisk US | Published 29 August 2017
The devastation caused by Hurricane Harvey in Houston hits close to home for us at Novo Nordisk. Houston is the first city where we established our Cities Changing Diabetes Program in the U.S. and where we currently employ people who dedicate each of their days to bringing change to diabetes patients. These employees, and the patients we serve, may currently be displaced from their homes as a result of the damage and ensuring their safety as well as assisting the many individuals in need in the Houston area is mission critical.
Following a disaster, no one living with diabetes should have to worry about getting the medicines they need. That’s why we’re working on the ground with long-time disaster relief partner, AmeriCares, for product donations (including our medicines) to non-profit organizations. All inquiries from non-profit organizations should be directed to AmeriCares via 800-486-HELP.
We’re also dedicated to providing relief to our impacted employees in the form of time off, product assistance, household relief and financial assistance as necessary for clothing, food and other items.
Finally, we’ll be matching employee contributions to the American Red Cross and we’re pledging $150,000 to the local Houston Health Foundation.
Even after Hurricane Harvey passes, we know the damage inflicted by the storm will last for weeks and months to come. Commitment to our community is strongest during these challenging times and our hearts are with Houston.
To learn more about what you can do to help the victims in Houston, several resources are provided here.
We use Facebook as our commenting platform. By entering your comment above you acknowledge that the information you post will not only be subject to Novo Nordisk community guidelines but will be posted on Facebook in accordance with their Terms of Service and Data Policy and subject to their Community Standards.
Editor’s note: Bobby Cipolla took another position outside of Novo Nordisk. Our commitment to diversity and inclusion remains strong, and the new leader of this Employee Resource Group is Stephen Barth, senior CRA – field management.
Our Chief Medical Officer has diabetes and a child with diabetes.
We talk with Todd Hobbs, vice president and chief medical officer for Novo Nordisk in North America. Todd brings a unique perspective to his job title – he was diagnosed with type 1 diabetes nearly 30 years ago and one of his sons has been a type 1 since the age of 5.
We hear from more and more people living with diabetes about the challenges they face affording healthcare, including the medicines we make. We take this issue seriously and have been thinking about what we can do to better support patients.